According to Zhitong Finance App, Hengrui Pharmaceutical (01276) issued an announcement. As of October 31, 2026, the company's share repurchase plan was a total of 1,6362 million A-share shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.025% of the company's total share capital. The highest purchase price was RMB 46.33 yuan/share, and the lowest price was RMB 43.10 per share. The total amount paid was RMB 73.8849 million (excluding transaction fees).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.